Noisy ← this week

The world is being quietly rearranged by people who write very long documents.

April 6, 2026
Federal Register
The title they went with
Medicare Program; Contract Year 2027 and Certain Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program Noisy translates that to

Medicare gave insurers an $18.6 billion raise by deleting the tests they were failing

CMS deleted the metrics insurers were gaming and called it a quality improvement.
What happened
New rules require Medicare Advantage plans to provide more detailed information about prescription drug costs and coverage. This means beneficiaries will have a clearer picture of what they will pay for their medications.
before Star Ratings based on metric optimization without access verification
after Star Ratings tied to measurable doctor availability and drug formulary coverage
Why this matters
For years, beneficiaries have struggled to understand the true cost of their medications under Medicare Advantage plans. This rule aims to bring transparency to those opaque drug pricing structures. It means beneficiaries can make more informed choices about their coverage, potentially saving money. It also puts pressure on plans to offer more competitive drug pricing.
A teacher improves her class average by removing the questions the students got wrong.
Who wins, who loses
who wins Medicare Advantage insurers, who received a formal $18.6 billion payment increase because the measures they were failing were quietly removed from the test.
who loses Low-income and disabled enrollees, who were the specific population the Biden-era Health Equity Index was designed to reward plans for serving, and who now watch that reward get eliminated before it ever paid out.
also Anyone on Medicare Advantage who has tried to see a specialist, and the insurers who are now being paid more not to fix that.
Jargon decoder
Part C Medicare Advantage — private insurance alternative to traditional Medicare
Part D Medicare prescription drug coverage
formulary The list of drugs an insurance plan agrees to cover
Star Ratings Quality scores Medicare uses to judge health insurance plans and determine how much money insurers receive
The signal
Why this hasn't landed yet
The rule is a contract-year amendment to existing CMS regulations, which means it reads like a technical update rather than a policy reversal — and the $18.6 billion figure requires understanding the Star Ratings bonus structure before it becomes legible as news.
What happens next
Advocacy groups will spend the next 18 months documenting whether the new network adequacy and formulary access requirements produce measurable access gains — the same work they did after the CY2024 behavioral health standards, which were added the same year other network standards were quietly loosened.
The catch
Insurers already demonstrated in prior cycles that they can game specific metrics by selectively reminding doctors before sampling windows, so adding new access requirements without an auditing mechanism gives plans a familiar surface to optimize against rather than a genuine standard to meet.
The longer story
The longer arc
Star Ratings have been tied to bonus payments since 2012, and average plan scores have climbed from 3.71 stars in 2013 to above 4 stars by 2018 without evidence of commensurate access improvement — each reform cycle has produced higher scores and inconclusive outcomes, and this rule continues that sequence.
Part of a pattern
The Trump administration's broader Medicare Advantage deregulatory posture is consistent here: the same CY2027 rule that adds network adequacy language also eliminates the Health Equity Index reward, continues a rollback of prior authorization rules, and produces a net payment increase — access language added, access incentives removed, payments up.
If you insist
Read the original →
The Sendoff
The rule updates Star Ratings, marketing, drug coverage, enrollment, special needs plans, and other programmatic areas. The title mentions doctor ratings.